Feasibility Study of the SEGER Device in Laparoscopic Gastrointestinal Surgery

This is a first-in-human feasibility study designed to evaluate the safety and performance of the SEGER device in patients undergoing elective laparoscopic gastrointestinal surgery requiring intracorporeal anastomosis. The study will include patients undergoing procedures such as small bowel-small bowel and colorectal anastomoses. The SEGER device is intended to facilitate closure of enterotomies and support intracorporeal anastomosis during minimally invasive surgery. The primary objective of the study is to assess the safety of the device and its performance during surgery. Secondary objectives include evaluation of technical success, intraoperative usability, and early postoperative outcomes.

NCT Number	NCT07508592
Lead Sponsor	Seger Surgical Solutions
Conditions	Colon Neoplasms, Crohn Disease (CD), Obesity & Overweight
Enrollment	10 participants
Start Date	2026-02-17
Primary Completion	2026-06-01 (estimated)
Study Completion	2026-06-05 (estimated)
Updated on ClinicalTrials.gov	2026-06-29